Leuphasyl vs Palmitoyl Pentapeptide-4
A side-by-side research comparison of Leuphasyl and Palmitoyl Pentapeptide-4 across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Leuphasyl | Palmitoyl Pentapeptide-4 |
|---|---|---|
| Full name | Leuphasyl (Pentapeptide-18) | Palmitoyl Pentapeptide-4 (Matrixyl Original) |
| Category | Skin & Anti-Aging | Skin & Anti-Aging |
| Status | Research compound | Research compound |
| Mechanism | Binds enkephalin receptors on neuronal membranes, reducing calcium influx and neurotransmitter release at the presynaptic level. Works upstream of argireline. | Mimics collagen breakdown products (matrikines) that signal fibroblasts to produce new collagen matrix components including types I, III, and IV collagen. |
| Molecular weight | 599.7 Da | 802.05 Da |
| Half-life | 6-10 hours (topical) | N/A (topical depot effect) |
| Bioavailability | Moderate (topical) | Topical: ~8-12% penetration |
| Typical dose | 3-5% solution | 2-8% in formulation |
| Frequency | 2x daily | 2x daily |
| Route | Topical | Topical serum or cream |
Leuphasyl reported benefits
- Complements argireline action
- Reduces muscle tension
- Smooths expression lines
- Gentle mechanism
Palmitoyl Pentapeptide-4 reported benefits
- Proven collagen stimulation
- Wrinkle depth reduction
- Improved skin firmness
- Well-tolerated
Related comparisons
Research and educational reference only. Not medical advice.